BDX
$BDX
Becton, Dickinson and Company
Medical technology company making syringes, diagnostics, and infusion systems.
Healthcare$141.61
-3.55 (-2.45%)
Day Range$140.63 - $145.60
Prev Close$145.16
Analyst Rating
Buy
9 Buy / 12 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
BDX: AI Launch vs Revenue Headwinds
Becton Dickinson ($BDX) sits at a crossroads — new AI-enabled product launches could drive medium-term margin recovery, while FY26 revenue pressure and recent underperformance keep upside limited near term. Analysts remain mostly positive but the company will need clearer execution and better top-line visibility to re-rate.
Apr 6, 2026